126333-28-6|SKF-107457|phenyl ((2S)-4-((S)-2-((S)-2-aminopropanamido)propanamido)-2-hexanamido-3-(hydroxymethyl)butanoyl)-L-valinate|-范德生物科技公司

SKF-107457

NMR下载 COA and HPLC MSDS下载
names：
phenyl ((2S)-4-((S)-2-((S)-2-aminopropanamido)propanamido)-2-hexanamido-3-(hydroxymethyl)butanoyl)-L-valinate
CAS号：
126333-28-6
MDL Number：
MF(分子式)： C28H45N5O7 MW(分子量)： 563.69
EINECS: Reaxys Number:
Pubchem ID: Brand:BIOFOUNT

货品编码	规格	纯度	价格 (¥)	现价(¥)	特价(¥)	库存描述	数量	总计 (¥)

大包装询价提供各种包装，敬请垂询
收藏商品商品点评加入购物车立即购买

快速询价

收起

你想询价的产品

*产品名称：

CAS号：

产品编号：

需求描述：

请准确填写您的联系方式，以便为您提供最好的服务。

*公司名称：

*电子邮箱：

联系人：

*电话：

*验证码：

询价

中文别名	phenyl ((2S)-4-((S)-2-((S)-2-aminopropanamido)propanamido)-2-hexanamido-3-(hydroxymethyl)butanoyl)-L-valinate
英文别名	SKF-107457; SKF 107457; SKF107457; Ala-Ala-Phepsi(CH(OH)CH2)Gly-Val-Val-OCH3;
CAS号	126333-28-6
Inchi	InChI=1S/C28H45N5O7/c1-6-7-9-14-22(35)32-24(20(16-34)15-30-26(37)19(5)31-25(36)18(4)29)27(38)33-23(17(2)3)28(39)40-21-12-10-8-11-13-21/h8,10-13,17-20,23-24,34H,6-7,9,14-16,29H2,1-5H3,(H,30,37)(H,31,36)(H,32,35)(H,33,38)/t18-,19-,20?,23-,24-/m0/s1
InchiKey	GLDYPYOVILJGHJ-FNKAFAPSSA-N
分子式 Formula	C28H45N5O7
分子量 Molecular Weight	563.69
溶解度Solubility
性状	Solid powder
储藏条件 Storage conditions	Dry, dark and store at 0-4℃ for short term (days to weeks) or -20℃ for long term (Store correctly 2-3years).

产品说明	SKF-107457(CAS:126333-28-6):仅限应用于工业或者科学研究过程中非医疗目的，不应用于人类或动物的临床诊断以及治过程疗，该产品非药用，非食用。
Introduction	SKF-107457 is a HIV protease type 1 inhibitor, and are hexapeptide substrate analogues with the scissile bond being replaced by a hydroxyethylene isostere.
Application1
Application2
Application3

警示图
危险性	Warning
危险性警示
安全声明
安全防护
备注

[1]Murthy KH, Winborne EL, Minnich MD, Culp JS, Debouck C. The crystal structures at 2.2-A resolution of hydroxyethylene-based inhibitors bound to human immunodeficiency virus type 1 protease show that the inhibitors are present in two distinct orientations. J Biol Chem. 1992 Nov 15;267(32):22770-8. PubMed PMID: 1429626.

[2]Wood SJ, Wetzel R. A novel method for the incorporation of glycoprotein-derived oligosaccharides into neoglycopeptides. Bioconjug Chem. 1992 Sep-Oct;3(5):391-6. PubMed PMID: 1420438.

[3] Zhao B, Winborne E, Minnich MD, Culp JS, Debouck C, Abdel-Meguid SS. Three-dimensional structure of a simian immunodeficiency virus protease/inhibitor complex. Implications for the design of human immunodeficiency virus type 1 and 2 protease inhibitors. Biochemistry. 1993 Dec 7;32(48):13054-60. PubMed PMID: 8241159.

[4] Verkhivker GM. Empirical free energy calculations of human immunodeficiency virus type 1 protease crystallographic complexes. II. Knowledge-based ligand-protein interaction potentials applied to thermodynamic analysis of hydrophobic mutations. Pac Symp Biocomput. 199

6:638-52. PubMed PMID: 9390264.

对不起，暂无产品评价！

MSDS

SDS 1.0 中文

展开

SDS 1.0 英文

展开